|
| | 99TH GENERAL ASSEMBLY
State of Illinois
2015 and 2016
HB3517 Introduced , by Rep. Robert F. Martwick SYNOPSIS AS INTRODUCED:
|
| |
Amends the Pharmacy Practice Act. Provides that beginning July 1, 2015, every new or refilled prescription for a Schedule II controlled substance shall only be dispensed in a medicine locking closure package. Defines "medicine locking closure package" and "Schedule II controlled substance". Provides that the medicine locking closure package may not be reusable. Provides that the medicine locking closure package must be dispensed by the pharmacy with instructions for patient use. Provides that the manufacturer of the medicine locking closure package must make assistance available online or through a toll-free number for patients. Effective immediately.
| |
| | |
| | A BILL FOR |
|
|
| | HB3517 | | LRB099 10752 HAF 31047 b |
|
|
| 1 | | AN ACT concerning regulation.
|
| 2 | | Be it enacted by the People of the State of Illinois,
|
| 3 | | represented in the General Assembly:
|
| 4 | | Section 5. The Pharmacy Practice Act is amended by adding |
| 5 | | Section 16c as follows:
|
| 6 | | (225 ILCS 85/16c new) |
| 7 | | Sec. 16c. Medicine locking closure package. |
| 8 | | (a) As used in this Section: |
| 9 | | "Medicine locking closure package" means any alphanumeric |
| 10 | | combination locking closure mechanism that can only be unlocked |
| 11 | | with a user-generated, resettable alphanumeric code in |
| 12 | | combination with an amber prescription container that forms a |
| 13 | | package that allows only the person with the prescription in |
| 14 | | the package access to the medicine. |
| 15 | | "Schedule II controlled substance" means a Schedule II |
| 16 | | controlled substance under the United States Controlled |
| 17 | | Substances Act and 21 CFR 1308. |
| 18 | | (b) Beginning July 1, 2015, every new or refilled |
| 19 | | prescription for a Schedule II controlled substance shall only |
| 20 | | be dispensed in a medicine locking closure package. The |
| 21 | | medicine locking closure package may not be reusable. The |
| 22 | | medicine locking closure package must be dispensed by the |
| 23 | | pharmacy with instructions for patient use. The manufacturer of |